A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children
Clinical trial NCT04070326 · COMPLETED
Trial details
- NCT number
- NCT04070326
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-19
- Primary completion
- 2021-10-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.